InMed Pharmaceuticals Appoints John Bathery to Board of Directors; Bryan Baldasare to Step Down

Reuters2025-10-16
InMed Pharmaceuticals Appoints John Bathery to Board of Directors; Bryan Baldasare to Step Down

InMed Pharmaceuticals Inc. has appointed John Bathery to its Board of Directors, effective immediately. Bathery brings over 30 years of experience in the pharmaceutical industry, including leadership in global business development and corporate partnerships. The company also announced that Bryan Baldasare will not stand for re-election at the upcoming Annual General Meeting in December 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 270677) on October 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment